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Glycosylation of natural products can alter their solubility and bioavailability, among other properties, which 
makes glycosyltransferases useful tools for increasing the production and/or generating novel compounds in 
microbial cell factories. However, the discovery and screening of new enzymes and engineered variants is often 
a low-throughput endeavor due to the need for over-expression and purification prior to in vitro experiments, 
which do not necessarily represent the in vivo activities of the enzyme. Therefore, a genetic biosensor 
controlling GFP expression was developed based on the flavonoid responsive transcriptional-repressor QdoR 
and expressed in E. coli. Due to the induced fluorescent response upon feeding the flavonoids Quercetin and 
Kaempferol, but not to their glucosides, the activity of UDP-dependent glycosyltransferases (UGTs) could be 
screened in vivo. Furthermore, a variant of QdoR was generated by directed evolution that showed greater 
dose-responsiveness and proved to allow greater discrimination of cellular populations and was thus more 
useful for in vivo UGT screening. The designed biosensor-based method will greatly increase the throughput of 





















































Quercetin + UGT expression
Figure 1 – Expression of flavonoid UGT results in significant decrease 
of fluorescence due to glycosylation of the flavonoid Quercetin. 
 
